Edition:
United Kingdom

Medivir AB (MVIRb.ST)

MVIRb.ST on Stockholm Stock Exchange

35.65SEK
17 Aug 2018
Change (% chg)

-0.10kr (-0.28%)
Prev Close
35.75kr
Open
35.65kr
Day's High
36.00kr
Day's Low
34.75kr
Volume
29,604
Avg. Vol
45,848
52-wk High
81.75kr
52-wk Low
32.10kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.80 -3.881
Mar '18 4.50 -3.175
FY 2017 Dec '17 4.24 -5.078
Sep '17 5.10 -3.934
Jun '17 9.50 -3.905
Mar '17 17.80 -3.356
FY 2016 Dec '16 9.90 -4.502
Sep '16 25.70 -2.012
Jun '16 36.90 -2.195
Mar '16 20.60 -2.214
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 70.00 70.00 70.00 --
Year Ending Dec-19 1 6.00 6.00 6.00 --
Earnings (per share)
Year Ending Dec-18 1 -16.71 -16.71 -16.71 -16.40
Year Ending Dec-19 1 -15.19 -15.19 -15.19 -2.60
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. 164.95 300.64 45.44
P/E Low - Last 5 Yrs. 2.71 92.08 24.26
Beta 1.15 0.93 0.89
Price to Sales (TTM) 22.18 114.98 5.75
Price to Book (MRQ) 2.04 15.51 5.00
Price to Tangible Book (MRQ) 2.41 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg 0.00 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -74.25 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -10.32 80.50 5.64
Sales - 5 Yr. Growth Rate -33.18 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -77.87 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago -79.63 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 43.72 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 7.46 1.91 2.22
Current Ratio (MRQ) 7.46 5.53 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -216.24 -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 73.51 39.17 54.37
Gross Margin - 5 Yr. Avg. 87.76 50.57 52.17
EBITD Margin (TTM) -524.51 -- --
EBITD - 5 Yr. Avg 31.55 -603.21 10.65
Operating Margin (TTM) -579.98 -759.76 4.32
Operating Margin - 5 Yr. Avg. 25.60 -625.13 6.06
Pre-Tax Margin (TTM) -574.81 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. 25.38 -628.46 6.49
Net Profit Margin (TTM) -560.05 -734.98 1.48
Net Profit Margin - 5 Yr. Avg. 22.08 -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. 13.02 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 537,120 23,229,989 860,375,103
Net Income/Employee (TTM) -3,008,163 3,144,143 101,207,184
Receivable Turnover (TTM) 0.90 20.89 5.87
Inventory Turnover (TTM) 1.55 2.46 3.41
Asset Turnover (TTM) 0.05 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.11 -0.16 11.13
Return on Assets - 5 Yr. Avg. 8.67 3.50 12.40
Return on Investment (TTM) -33.02 1.78 14.61
Return on Investment - 5 Yr. Avg. 9.69 2.55 16.13
Return on Equity (TTM) -34.12 3.28 16.33
Return on Equity - 5 Yr. Avg. 9.91 3.42 17.39
  1 Year 3 Year 5 Year
Sales % -80.38 -40.70 -33.18
EPS (TTM) % -1,112.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Medivir AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.77 -- 61 53
13 Week -4.10 -- 87 66
26 Week 1.81 -- 99 80
52 Week 4.07 -- 99 50
YTD -28.32 -- 45 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 30.36%
# of Holders: 24
Total Shares Held: 7,373,745
3 Mo. Net Change: 1,490,064
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 8
# Reduced Positions: 3
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.